Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. LaBaer's efforts involve leveraging the Center's formidable resources for the discovery and validation of biomarkers - unique molecular fingerprints of disease - which can provide early warning for those at risk of major illnesses, including cancer and diabetes. Dr. LaBaer’s team is focused on identifying genes that are especially important in designing therapies to treat BLBC and other aggressive cancers.
Claudio Nicolini, Rosanna Spera, Fernanda Festa, Luca Belmonte, Shaorong Chong, Eugenia Pechkova and Joshua Labaer
Research Article: J Nanomed Nanotechnol 2013, 4:181